Jusqu’où aller dans la désescalade thérapeutique en chirurgie du cancer du sein infiltrant : contre la désescalade
| Autor: | Pierre-Emmanuel Colombo, A. Mourregot, Philippe Rouanet |
|---|---|
| Přispěvatelé: | Département de chirurgie, CRLCC Val d'Aurelle - Paul Lamarque, Institut de Recherche en Cancérologie de Montpellier (IRCM - U1194 Inserm - UM), CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM) |
| Rok vydání: | 2016 |
| Předmět: |
Cancer Research
medicine.medical_specialty Mastectomie conventionnelle medicine.medical_treatment Chirurgie cancer du sein [SDV.CAN]Life Sciences [q-bio]/Cancer 03 medical and health sciences 0302 clinical medicine Breast cancer Hospitalisation medicine Radiology Nuclear Medicine and imaging Traditionai hospitaiization 030212 general & internal medicine Mastectomy Neoadjuvant therapy Curage axillaire MESH: Humans business.industry MESH: Sentinel Lymph Node Hematology General Medicine Ductal carcinoma Sentinel node medicine.disease Oncopiasty Oncoplastie 3. Good health Surgery MESH: Carcinoma Ductal Breast Breast cancer surgery Axiiiary dissection Oncology 030220 oncology & carcinogenesis Ambulatory Axillary Dissection MESH: Axilla business MESH: Female MESH: Breast Neoplasms [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology |
| Zdroj: | Bulletin du Cancer Bulletin du Cancer, John Libbey Eurotext, 2016, 103 (6), pp.S96-S98. ⟨10.1016/S0007-4551(16)30152-7⟩ |
| ISSN: | 0007-4551 1769-6917 |
| DOI: | 10.1016/s0007-4551(16)30152-7 |
| Popis: | International audience; CONS: Therapeutic de-escalation in breast cancer surgery is not recommanded for all patients. Concerning the axillary management, there are still some contraindications for practicing sentinel node, and avoiding axillary dissection is not safe for more than 3 positive sentinel nodes and in the absence of adjuvant treatment. Mastectomy can also be preferred by patients rather than conservative surgery, especially in case of genetic mutation, or for oncological reasons. Larger glandular resections, known as oncoplasties, should also be chosen in case of associated ductal carcinoma in situ and risky subgroups of local recurrence after neoadjuvant therapy. Finally, all patients will not benefit from ambulatory surgery. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|